Ardent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ardent Health, Inc. on June 20, 2025, regarding an event that occurred on June 16, 2025. The filing addresses a significant change in executive leadership within the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
On June 16, 2025, David Schultz ceased serving as President, Hospital Operations and departed the Company effective immediately. The Company and Mr. Schultz mutually determined this departure. The separation is classified as a "Qualifying Termination" under the Company's Executive Severance Plan, entitling Mr. Schultz to severance and related benefits subject to the plan's terms.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, outlook, or management commentary regarding future operations. The primary contingency noted is the obligation to provide severance benefits to the departing executive as detailed in the Company's 2025 Proxy Statement (Schedule 14A) and the Executive Severance Plan filed as an exhibit to the Q2 2024 Form 10-Q.
Key Facts for Investor Verification
- David Schultz's departure as President, Hospital Operations was effective immediately on June 16, 2025.
- The departure is treated as a "Qualifying Termination" triggering severance benefits.
- Specific severance amounts are not listed in this 8-K; investors should review the 2025 Proxy Statement and the Q2 2024 Form 10-Q for details.
- No financial results or operational metrics are included in this specific filing.